by Thomas Boehm  

The following is a short synopsis of the article "How can we explain the American dominance in biomedical research and development?" written by Thomas Boehm, Medical Director in the clinical development team at Jerini AG. The article was first published in The Journal of Medical Marketing (HS publications, Vol. 5, 2 158–166.)

by Peter J. Winzer  

The fundamental question of "What does it take to become a world-class research institution?" is constantly debated in public media these days, especially in Europe, where the top American universities and research institutions are often taken as role models. “What do they have that we don't have? What are their key strengths? What do we have to do to establish a world-class research reputation?” Or possibly: “Do we have such a reputation already?”